Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia.
Scheepers
Floortje E
FE
Gispen-De Wied
Christine C
CC
Westenberg
Herman G M
HG
Kahn
René S
RS
D000328:Adult; D000704:Analysis of Variance; D014150:Antipsychotic Agents / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D001569:Benzodiazepines; D018698:Glutamic Acid / Q000134:cerebrospinal fluid*; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D012559:Schizophrenia / Q000134:cerebrospinal fluid* / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D018698:Glutamic Acid; D000077152:Olanzapine